|
|
 |
 |
| |
Printable version |
|
Annales de Biologie Clinique. Volume 69, Number 2, 239-45, Mars-Avril 2011, Qualité-Accréditation
|
Résumé
Texte intégral
|
Author(s) : Michèle Fonfrède, Jean Paul Couaillac, Christine Augereau, Danny De Moüy, Jean Pierre Lepargneur, Anton Szymanowicz, Joseph Watine |
Summary : We have evaluated the methodological quality of the
Rémic (microbiology guidelines – bacteriology and mycology) of the Société française de microbiologie (edition2007), using to AGREE criteria, which are consensual at an international level, in particular at the the World Health Organisation (WHO) and at the European Union. The methodological quality of the
Rémic appears to be sub-optimal. These shortcomings in quality are mainly observed in AGREE domain n° 5 (applicability), in AGREE item n° 5 (patients’ opinions were not considered), and in AGREE item n° 23 (conflicts of interest were not declared). The users of the
Rémic must be aware of these few methodological shortcomings in order for them to be careful before they put its recommendation in practice. In conclusion, we advise the editors of the
Rémic to insert at least a methodological chapter in their next edition. |
Keywords : clinical practice guidelines,
Rémic, recommendations, bacteriology, mycology, AGREE Quality |
|